These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 6754569)
41. Amino-terminal fragment of urokinase-type plasminogen activator inhibits its plasminogen activation. Sun Z; Zhang PX; Wang P; Gurewich V; Shen HY; Liu JN Thromb Res; 2002 Apr; 106(2):105-11. PubMed ID: 12182908 [TBL] [Abstract][Full Text] [Related]
42. A serpin-induced extensive proteolytic susceptibility of urokinase-type plasminogen activator implicates distortion of the proteinase substrate-binding pocket and oxyanion hole in the serpin inhibitory mechanism. Egelund R; Petersen TE; Andreasen PA Eur J Biochem; 2001 Feb; 268(3):673-85. PubMed ID: 11168406 [TBL] [Abstract][Full Text] [Related]
43. Comparative studies on urokinase and plasminogen activator from cultured pancreatic carcinoma. Wu MC; Yunis AA Int J Biochem; 1979; 10(12):1001-6. PubMed ID: 116877 [No Abstract] [Full Text] [Related]
44. [Product E, urokinase and uropepsinogen in the urine of diabetic children]. Symonides-Lawecka A; Galczak W; Olech K; Wysocki M Pediatr Pol; 1978 May; 53(5):593-8. PubMed ID: 683753 [No Abstract] [Full Text] [Related]
45. [Primary structure of 20S,22R-cholesterol-hydroxylating cytochrome P-450 from bovine adrenal cortex mitochondria. IV. Structure of peptides of thermolytic and limited tryptic hydrolysis of the fragment F1; peptides of cyanogen bromide hydrolysis of cytochrome P-450. Complete amino acid sequence]. Chashchin VL; Lapko VN; Adamovich TB; Lapko AG; Kuprina NS Bioorg Khim; 1985 Aug; 11(8):1048-67. PubMed ID: 3904759 [TBL] [Abstract][Full Text] [Related]
46. Primary structure, biochemical and physiological aspects of hemoglobin from South American lungfish (Lepidosiren paradoxus, Dipnoi). Rodewald K; Stangl A; Braunitzer G Hoppe Seylers Z Physiol Chem; 1984 Jun; 365(6):639-49. PubMed ID: 6090299 [TBL] [Abstract][Full Text] [Related]
47. Complete amino acid sequence of bovine glia maturation factor beta. Lim R; Zaheer A; Lane WS Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5233-7. PubMed ID: 2196564 [TBL] [Abstract][Full Text] [Related]
48. Ligand binding to the tissue-type plasminogen activator kringle 2 domain: structural characterization by 1H-NMR. Byeon IJ; Kelley RF; Mulkerrin MG; An SS; LlinĂ¡s M Biochemistry; 1995 Mar; 34(9):2739-50. PubMed ID: 7893685 [TBL] [Abstract][Full Text] [Related]
49. Proteolytic regulation of the urokinase receptor/CD87 on monocytic cells by neutrophil elastase and cathepsin G. Beaufort N; Leduc D; Rousselle JC; Magdolen V; Luther T; Namane A; Chignard M; Pidard D J Immunol; 2004 Jan; 172(1):540-9. PubMed ID: 14688365 [TBL] [Abstract][Full Text] [Related]
50. Purification and characterization of two forms of urokinase. Soberano ME; Ong EB; Johnson AJ; Levy M; Schoellmann G Biochim Biophys Acta; 1976 Oct; 445(3):763-73. PubMed ID: 974102 [TBL] [Abstract][Full Text] [Related]
51. Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen. Eaton DL; Fless GM; Kohr WJ; McLean JW; Xu QT; Miller CG; Lawn RM; Scanu AM Proc Natl Acad Sci U S A; 1987 May; 84(10):3224-8. PubMed ID: 3472206 [TBL] [Abstract][Full Text] [Related]
53. Relationships between structure and function of tissue-type plasminogen activator. Rijken DC Klin Wochenschr; 1988; 66 Suppl 12():33-9. PubMed ID: 3126346 [TBL] [Abstract][Full Text] [Related]
54. Human plasma prekallikrein, a zymogen to a serine protease that contains four tandem repeats. Chung DW; Fujikawa K; McMullen BA; Davie EW Biochemistry; 1986 May; 25(9):2410-7. PubMed ID: 3521732 [TBL] [Abstract][Full Text] [Related]
55. Hemoglobins of an amphibia, the neotenous Ambystoma mexicanum. Complete amino-acid sequence of the alpha chain of the major component using automatic solid-phase Edman degradation. Boissel JP; Wajcman H; Labie D Eur J Biochem; 1980 Feb; 103(3):613-21. PubMed ID: 7358052 [TBL] [Abstract][Full Text] [Related]
56. The genetic relationships between the kringle domains of human plasminogen, prothrombin, tissue plasminogen activator, urokinase, and coagulation factor XII. Castellino FJ; Beals JM J Mol Evol; 1987; 26(4):358-69. PubMed ID: 3131537 [TBL] [Abstract][Full Text] [Related]
57. Effect of orthostatic changes on urokinase excretion. Wilcox GM; Hial V; Horwitz D; Pisano JJ; Keiser HR Thromb Haemost; 1978 Feb; 39(1):69-73. PubMed ID: 580506 [TBL] [Abstract][Full Text] [Related]
58. Characterization of radioimmunoassays for high- and low-molecular weight urokinases and estimation of different molecular forms of urokinase in urine and plasma. Cheung T; Lui AY; Lau HK J Lab Clin Med; 1993 Mar; 121(3):461-71. PubMed ID: 8445294 [TBL] [Abstract][Full Text] [Related]
59. The complete amino acid sequence of mitochondrial glutamic oxaloacetic transaminase from rat liver. Huynh QK; Sakakibara R; Watanabe T; Wada H J Biochem; 1981 Sep; 90(3):863-75. PubMed ID: 7309704 [TBL] [Abstract][Full Text] [Related]
60. Characterization of domain deletion and/or duplication mutants of a recombinant chimera of tissue-type plasminogen activator and urokinase-type plasminogen activator (rt-PA/u-PA). Nelles L; Lijnen HR; Van Nuffelen A; Demarsin E; Collen D Thromb Haemost; 1990 Aug; 64(1):53-60. PubMed ID: 2148847 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]